The California Stem Cell Report

Share this post

User's avatar
The California Stem Cell Report
'All Not Well in Gene Therapy World' -- Denial of Coverage, Delays and Complications

'All Not Well in Gene Therapy World' -- Denial of Coverage, Delays and Complications

Implications for $12 billion California program and its mandate for affordability

David Jensen's avatar
David Jensen
Sep 17, 2024
∙ Paid
1

Share this post

User's avatar
The California Stem Cell Report
'All Not Well in Gene Therapy World' -- Denial of Coverage, Delays and Complications
Share

It is one thing to talk abstractly about the astronomical costs of revolutionary gene therapies. It is another to dive into the personal battles with insurance companies and see the physical and emotional pain of the patients and their families.  

“My heart sank,” said Amanda Reed. “It was horrible. I thought, ‘Am I going to lose my boys?”

Bloomberg News

Keep reading with a 7-day free trial

Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 David Jensen
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share